SCHEMBL6957834

SCHEMBL6957834

CS(=O)(=O)O[C@@H]1CCc2cc(F)ccc2C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 1/20 0.45
HTR1B P28222 1/20 0.45
PSEN1 P49768 2/20 0.39
PSEN2 P49810 2/20 0.39
APH1B Q8WW43 2/20 0.39
NCSTN Q92542 2/20 0.39
APH1A Q96BI3 2/20 0.39
PSENEN Q9NZ42 2/20 0.39
SRD5A1 P18405 4/20 0.38
ACHE P22303 2/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
CYP2B6 P20813 1/20 0.36
SLC6A4 P31645 1/20 0.35
TSHR P16473 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6958050 1.00 HTR1D (0.45) HTR1DHTR1BPSEN1PSEN2APH1B
SCHEMBL6957838 1.00 HTR1D (0.45) HTR1DHTR1BPSEN1PSEN2APH1B
SCHEMBL6958304 0.94 HTR1D (0.39) HTR1DHTR1BPSEN1PSEN2APH1B
SCHEMBL6951816 0.94 HTR1D (0.39) HTR1DHTR1BPSEN1PSEN2APH1B
SCHEMBL6951811 0.94 HTR1D (0.39) HTR1DHTR1BPSEN1PSEN2APH1B
SCHEMBL6951218 0.83 HDAC8 (0.32) ACHECA1CA2CYP1A2CYP3A4
SCHEMBL7958716 0.82 CA1 (0.53) ACHECA1CA2CYP3A4ALDH1A1
SCHEMBL6953263 0.80 CA1 (0.45) CA1CA2SLC6A4HTR2C
SCHEMBL4857120 0.80 CA1 (0.45) CA1CA2SLC6A4HTR2C
SCHEMBL6957962 0.78 HTR6 (0.32) ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0757677-B1 BENZOCYCLOHEXYLIMIDAZOLETHIONE DERIVATIVES SYNTEX LLC (US) 2003-06-18 EP disclosed
US-5719280-A REACTING AMINE SUBSTITUTED BENZOCYCLOALKANE WITH DIALKYLOXYACETALDEHYDE IN PRESENCE OF REDUCING AGENT OR CATALYTIC HYDROGENATION, TREATING WITH THIOCYANIC ACID SYNTEX (U.S.A.) INC. (US) 1998-02-17 US disclosed
US-5538988-A CARDIOVASCULAR DISORDERS AND DOPAMINE HYDROLASE ENZYME INHIBITORS SYNTEX (U.S.A.) INC. 1996-07-23 US disclosed